|
Snowdon defends renal study - ABC Online |
ABC Online
The much anticipated Central Australian Renal Study was released this week and while some have voiced disappointment in the report, Minister for Indigenous Health, Warren Snowdon, is standing by the study.
|
|
NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA - PR Newswire (press release) |
PR Newswire (press release)
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure
|
Improved technology for dialysis clients across the Kootenays - The Castlegar Source |
The Castlegar Source
by Contributor on 29 Jun 2011 Twenty-six new Gambro Artis hemodialysis machines have been installed in community dialysis units across the Kootenays, but none in Trail or in Nelson. The machines replace aging equipment with state-of-the-art technology
|
Lab-grown blood vessels - The Hindu |
The Hindu
Functioning blood vessels that aren't rejected by the immune system could be used to make durable shunts for kidney dialysis, and potentially to improve treatment for children with heart defects and adults needing coronary or other bypass graft surgery
|
Ambulatory vs In-Office BP Better for Predicting CKD - Medscape |
Medscape
Roberto Minutolo, MD, PhD, from the Division of Nephrology, Second University of Naples, Italy, and colleagues reported their findings in the June 27 issue of the Archives of Internal Medicine. According to the researchers, ambulatory BP measurement
|
|
|
|
<< Start < Prev 821 822 823 824 825 826 827 828 829 830 Next > End >>
|
Page 825 of 2630 |